Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Agoram

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|February 21, 2014
Evaluating systems pharmacology models is different from evaluating standard pharmacokinetic-pharmacodynamic modelsB Agoram
Journal of Biomechanical Engineering|September 21, 2001
Coupled macroscopic and microscopic scale modeling of fibrillar tissues and tissue equivalentsB Agoram, V H Barocas
Advanced Drug Delivery Reviews|September 29, 2001
Predicting the impact of physiological and biochemical processes on oral drug bioavailabilityB Agoram, W S Woltosz, M B Bolger
CPT: Pharmacometrics & Systems Pharmacology|June 12, 2014
Effects of IL-1β-Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying MechanismsR Palmér, E Nyman, M Penney, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 7, 2017
Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and EstimationB Ribba, H P Grimm, B Agoram, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|February 21, 2014
Evaluating systems pharmacology models is different from evaluating standard pharmacokinetic-pharmacodynamic modelsB Agoram
Journal of Biomechanical Engineering|September 21, 2001
Coupled macroscopic and microscopic scale modeling of fibrillar tissues and tissue equivalentsB Agoram, V H Barocas
Advanced Drug Delivery Reviews|September 29, 2001
Predicting the impact of physiological and biochemical processes on oral drug bioavailabilityB Agoram, W S Woltosz, M B Bolger
CPT: Pharmacometrics & Systems Pharmacology|June 12, 2014
Effects of IL-1β-Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying MechanismsR Palmér, E Nyman, M Penney, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 7, 2017
Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and EstimationB Ribba, H P Grimm, B Agoram, et al.
Pageof 1